Biomarker testing has become “increasingly critical” in the care of non-small cell lung cancer.A new investigation into testing rates proved “reassuring” to Kenneth L. Kehl, MD, MPH, assistant ...
With durable responses, encouraging survival outcomes, and evidence that some patients may become eligible for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback